𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of IV vinflunine in patients with chemotherapy naive metastatic malignant melanoma

✍ Scribed by I.N. Olver; M.J. Byrne; E. Walpole; D. Vorobiof; C. Jacobs; K. Maart; S. Hewitt; G. McAdam; J.C. Pouget; M.C. Pinel

Book ID
116429373
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
129 KB
Volume
43
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of spirogermanium in pa
A phase II study of spirogermanium in patients with metastatic malignant melanoma
✍ Elizabeth Eisenhauer; Ian Kerr; Audley Bodurtha; Neill Iscoe; Peter McCulloch; K πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 205 KB

The National Cancer Institute of Canada Clinical Trials Group conducted a phase II study of spirogermanium given daily for 5 days every 3 weeks to previously untreated patients with malignant melanoma. In 21 evaluable patients one complete response was seen (response rate 5%). Disease progression oc

Treatment of metastatic malignant melano
Treatment of metastatic malignant melanoma with trimetrexate: A phase II study
✍ Odujinrin, Oluwole ;Goldberg, David ;Doroshow, James ;Leong, Lucille ;Margolin, πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 361 KB

## Abstract Trimetrexate glucuronate, a nonclassical antifolate, was administered to 14 patients with recurrent and progressive metastatic malignant melanoma. Thirteen patients were evaluable for response and toxicity. Five patients had received prior treatment consisting of immunotherapy (one pati